Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gavin Kelly

Showing results (61-70 of 77) with videos related to

Pageof 8
Sort By:
Nature Communications|October 9, 2021
Characterisation of tumour microenvironment remodelling following oncogene inhibition in preclinical studies with imaging mass cytometryFebe van Maldegem, Karishma Valand, Megan Cole, et al.
The Journal of Investigative Dermatology|September 16, 2023
Mosaic BRAF Fusions Are a Recurrent Cause of Congenital Melanocytic Nevi Targetable by MAPK Pathway InhibitionSara Barberan Martin, Satyamaanasa Polubothu, Alicia Lopez Bruzos, et al.
The EMBO Journal|February 5, 2026
Cellular quiescence uncouples the proteome from the transcriptome in neural stem cellsAlice Rossi, Antoine Coum, Manon Madelenat, et al.
Nature|March 16, 2023
The dietary sweetener sucralose is a negative modulator of T cell-mediated responsesFabio Zani, Julianna Blagih, Tim Gruber, et al.
Nature Immunology|January 2, 2026
Cross-presentation of dead cell-associated antigens shapes the neoantigenic landscape of tumor immunityKok Haw Jonathan Lim, Oliver Schulz, Irene Lobon, et al.
Science Advances|November 1, 2024
Spatial multiplex analysis of lung cancer reveals that regulatory T cells attenuate KRAS-G12C inhibitor-induced immune responsesMegan Cole, Panayiotis Anastasiou, Claudia Lee, et al.
The Journal of Infection|August 22, 2025
Evaluation of Hepatitis B core-related antigen (HBcrAg) as a biomarker in cohorts from the United Kingdom and South AfricaLouise O Downs, Marion Delphin, Marije van Schalkwyk, et al.
The Journal of Investigative Dermatology|April 24, 2025
Cholesterol pathway gene variants and reduced keratinocyte cholesterol support a final common druggable pathway in hyperproliferative inflammatory skin diseasesMelissa Riachi, Dale Bryant, James Ellis, et al.
The Journal of Infection|August 23, 2025
Third exposure to COVID-19 infection or vaccination differentially impacts T cell responsesGift Ahimbisibwe, David Greenwood, Katalin Andrea Wilkinson, et al.
Plos One|March 21, 2024
COVID-19 in non-hospitalised adults caused by either SARS-CoV-2 sub-variants Omicron BA.1, BA.2, BA.4/5 or Delta associates with similar illness duration, symptom severity and viral kinetics, irrespective of vaccination historyHermaleigh Townsley, Joshua Gahir, Timothy W Russell, et al.
Pageof 8

Showing results (61-70 of 77) with videos related to

Sort By:
Pageof 8
Nature Communications|October 9, 2021
Characterisation of tumour microenvironment remodelling following oncogene inhibition in preclinical studies with imaging mass cytometryFebe van Maldegem, Karishma Valand, Megan Cole, et al.
The Journal of Investigative Dermatology|September 16, 2023
Mosaic BRAF Fusions Are a Recurrent Cause of Congenital Melanocytic Nevi Targetable by MAPK Pathway InhibitionSara Barberan Martin, Satyamaanasa Polubothu, Alicia Lopez Bruzos, et al.
The EMBO Journal|February 5, 2026
Cellular quiescence uncouples the proteome from the transcriptome in neural stem cellsAlice Rossi, Antoine Coum, Manon Madelenat, et al.
Nature|March 16, 2023
The dietary sweetener sucralose is a negative modulator of T cell-mediated responsesFabio Zani, Julianna Blagih, Tim Gruber, et al.
Nature Immunology|January 2, 2026
Cross-presentation of dead cell-associated antigens shapes the neoantigenic landscape of tumor immunityKok Haw Jonathan Lim, Oliver Schulz, Irene Lobon, et al.
Science Advances|November 1, 2024
Spatial multiplex analysis of lung cancer reveals that regulatory T cells attenuate KRAS-G12C inhibitor-induced immune responsesMegan Cole, Panayiotis Anastasiou, Claudia Lee, et al.
The Journal of Infection|August 22, 2025
Evaluation of Hepatitis B core-related antigen (HBcrAg) as a biomarker in cohorts from the United Kingdom and South AfricaLouise O Downs, Marion Delphin, Marije van Schalkwyk, et al.
The Journal of Investigative Dermatology|April 24, 2025
Cholesterol pathway gene variants and reduced keratinocyte cholesterol support a final common druggable pathway in hyperproliferative inflammatory skin diseasesMelissa Riachi, Dale Bryant, James Ellis, et al.
The Journal of Infection|August 23, 2025
Third exposure to COVID-19 infection or vaccination differentially impacts T cell responsesGift Ahimbisibwe, David Greenwood, Katalin Andrea Wilkinson, et al.
Plos One|March 21, 2024
COVID-19 in non-hospitalised adults caused by either SARS-CoV-2 sub-variants Omicron BA.1, BA.2, BA.4/5 or Delta associates with similar illness duration, symptom severity and viral kinetics, irrespective of vaccination historyHermaleigh Townsley, Joshua Gahir, Timothy W Russell, et al.
Pageof 8